Company Filing History:
Years Active: 1979
Title: Martin L Mortensen: Innovator in Immunosuppressive Methods
Introduction
Martin L Mortensen is a notable inventor based in Kila, Montana. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing methods that can aid in the treatment of organ transplant rejection and autoimmune diseases.
Latest Patents
Martin L Mortensen holds a patent for an immunosuppressive method utilizing dithiocarbamates. The patent describes novel .omega.-(alkoxycarbonyl)alkyl esters of dithiocarbanilic acid and certain aryl-substituted acids. These compounds are recognized as immunoregulatory agents, which are beneficial in addressing organ transplant rejection phenomena and autoimmune diseases such as arthritis. The invention also highlights the immunoregulatory use of .omega.-carboxyalkyl and .omega.-(alkoxycarbonyl)alkyl esters of dithiocarbanilic acid.
Career Highlights
Mortensen is affiliated with the California Polytechnic State University Foundation, where he continues to engage in research and development. His work has garnered attention for its potential applications in medical science, particularly in improving patient outcomes in transplant procedures.
Collaborations
Throughout his career, Martin has collaborated with esteemed colleagues, including Hewitt G Wight and Tracey G Call. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Martin L Mortensen is a distinguished inventor whose work in immunosuppressive methods has the potential to significantly impact the medical field. His innovative approaches to treating organ transplant rejection and autoimmune diseases highlight the importance of research in improving healthcare solutions.